Trading Statement

RNS Number : 3938S
Tristel PLC
09 September 2010
 



 

TRISTEL plc

("Tristel" or the "Company ")

 

Trading update, overseas expansion and results date

 

Tristel plc, the infection and contamination control business, is pleased to provide a trading update.

 

Tristel continues to see strong growth across the Group and trading results for the year ended 30 June 2010 are expected to be in line with market expectations. 

 

In addition the Company announces that it has established a branch office in Berlin, Germany. The Company has already commenced sales in Germany, Europe's largest healthcare market, and has introduced its Wipes System to Ear, Nose & Throat and Cardiology departments and its Stella decontamination system to Urology departments in hospitals.

 

More detail on the Company's geographical expansion will be given in the preliminary announcement of results for the year ended 30 June 2010. The Company will announce its results on 18 October 2010.

 

 

 

For further information, please contact:     

 

Tristel PLC


Paul Swinney, Chief Executive

Tel: 01638 721 500



Walbrook PR Ltd

Tel: 020 7933 8787

Paul McManus

Mob: 07980 541 893


paul.mcmanus@walbrookpr.com



FinnCap


Geoff  Nash/Rhydian Bankes (Corporate Finance)

Tel: 020 7600 1658

Simon Starr (Corporate Broking)


 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUQGBUPUPGR

Companies

Tristel (TSTL)
UK 100

Latest directors dealings